Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation: From obesity to memory deficits

Molecular Neurobiology

Volumn 18, Issue 1, 1998, Pages 1-22

  Raber, Jacob ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adrenal gland; Amygdala; Arginine vasopressin; Chronic stress; Cognitive deficits; Excitatory amino acids; Glucocorticoids; Hippocampus; Hypothalamus; Obesity

Indexed keywords

ARGIPRESSIN; EXCITATORY AMINO ACID; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; DEPRESSION; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MEMORY; MOUSE; NONHUMAN; OBESITY; RAT; RECEPTOR DENSITY; STRESS;

EID: 0031724136     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02741457     Document Type: Article

References (246)

1. Adolphs R., Tranel D., Damasio H. and Damasio A. (1994) Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature 372, 669-672.
2. Aguilera G. (1994) Regulation of pituitary ACTH secretion during chronic stress. Front. Neuroendocrinol. 15, 321-350.
3. Aguilera G., Lightman S. L. and Kiss A. (1993) Regulation of the hypothalamic-pituitary-adrenal axis during water deprivation. Endocrinology 132, 241-248.
4. Akana S. F., Chu A. C. and Dallman M. F. (1997) Corticosterone in the amygdala determines abdominal obesity in a state-dependent manner. Soc. Nerosci. Ann. Meeting 23, 1792 (abstr.).
5. Almawi W. Y., Beylum H. N., Rahme A. A. and Rieder M. J. (1996) Regulation of cytokine and cytokine receptor expressin by glucocorticoids. J. Leukocyte Biol. 60, 563-572.
6. Antoni F. A. (1986) Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endoc. Rev. 7, 351-378.
7. Appel N. M., Owens M. J., Culp S., Zaczek R., Contrera J. F., Bissette G., et al. (1991) Role for brain corticotropin-releasing factor in the weight-reducing effects of chronic fenfluramine treatments in rats. Endocrinology 128, 3237-3246.
8. Arase K., York D. A., Shimuzu H., Shargill N. and Bray G. A. (1988) Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats. Am. J. Physiol. 255, E255-259.
9. Arbel I., Kadar T., Silbermann M. and Levy A. (1994) The effects of long-term corticosterone administration on hippocampal morphology and cognitive performance of middle-aged rats. Brain Res. 657, 227-235.
10. Arias C., Arrieta I. and Tapia R. (1995) β-amyloid peptide fragment 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarized hippocampal slices. J. Neurosci. Res. 41, 561-566.
11. Auphan M., DiDonato J. A., Rosette C., Helmberg A. and Karin M. (1995) Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of 1-κB synthesis. Science 270, 286-290.
12. Bagley J. and Moghaddam B. (1997) Temporal dynamics of glutamate efflux in the prefrontal cortex and in the hippocampus following repeated stress: effects of preteatment with saline or diazepam. Neuroscience 77, 65-73.
13. Balcar V. J. and Li Y. (1992) Heterogeneity of high affinity uptake of L-glutamate and L-aspartate in the mammalian central nervous system. Life Sci. 51, 1467-1478.
14. Bardgett M. E., Taylor G. T., Csernansky J. G., Newcomer J. W. and Nock B. (1994) Chronic corticosterone treatment impairs spontaneous alternation behavior in rats. Behav. Neural. Biol. 61, 186-190.
15. Bartanusz V., Jezova D., Bertini L. T., Tilders F. J. H., Aubry J. M. and Kiss J. Z. (1993) Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons. Endocrinology 132, 895-902.
16. Beaulieu S., Pelletier G., Vaudry H. and Barden N. (1989) Influence of the central nucleus of the amygdala on the content of corticotropin-releasing factor in the median eminence. Neuroendocrinology 49, 255-261.
17. Bender B. G., Lerner J. A. and Poland J. E. (1991) Association between corticosteroids and psychologic change in hospitalized asthmatic children. Ann. Allergy 66, 414-419.
18. Benveniste H., Drejer J., Schousboe A. and Diemer N. H. (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369-1375.
19. Bjorntorp P. (1991) Metabolic implications of body fat distribution. Diabetes Care 14, 1132-1143.
20. Bodnoff S. R., Humphreys A. G., Lehman J. C., Diamond D. M., Rose G. M. and Meaney M. J. (1995) Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J. Neurosci. 15, 61-69.
21. Boston B. A., Blaydon K. M., Varnerin J. and Cone R. D. (1997) Independent and additive effects of central POMC and leptin pathways on marine obesity. Science 278, 1641-1644.
22. Britton D. R., Koob G. F., Rivier J. and Vale W. (1982) Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci. 31, 363-367.
23. Bruce B. K., King B. M., Phelps G. R. and Veita M. C. (1982) Effects of adrenalectomy and corticosterone administration on hypothalamic obesity in rats. Am. J. Physiol. 243, E152-157.
24. Busbridge N. J., Carnie J. A., Dascombe M. J., Johnston J. A. and Rothwell N. J. (1990) Adrenalectomy reverses the impaired pyrogenic responses to interleukin-beta in obese Zucker rats. Int. J. Obes. 14, 809-814.
25. Butterfield D. A. (1997) β-amyloid-associated free radical oxidative stress and neurotoxicity: Implications for Alzheimer's disease. Chem. Res. Toxicol. 10, 495-506.
26. Caputo F. A., Ali S. F., Wolff G. L. and Scallet A. C. (1996) Neonatal MSG reduces hypothalamic DA, beta-endorphin, and delays weight gain in genetically obese (A viable yellow/alpha) mice. Pharmacol. Biochem. Behav. 53, 425-432.
27. Chao H. M. and McEwen B. S. (1994) Glucocorticoids and the expression of mRNAs for neurotrophin, their receptors and GAP-43 in the rat hippocampus. Mol. Brain Res. 26, 271-276.
28. Chautard T., Boudouresque F., Guillaume V. and Oliver C. (1993) Effect of excitatory amino acid on the hypothalamic-pituitary-adrenal axis in the rat during the stress-hyporesponsive period. Neuroendocrinology 57, 70-78.
29. 3H]D-aspartate overflow in hippocampal cultures during cyanide-induced ischemia. Brain Res. 654, 8-14.
30. Chowdrey H. S., Jessop D. S. and Lightman S. L. (1991) Altered adrenocorticotropin, corticosterone and oxytocin responses to stress during chronic salt load. Neuroendocrinology 54, 635-638.
31. Cintra A., Fuxe K., Agnati L. F., Persson L., Härfstrand A., Zoli M., et al. (1987a) Evidence for the existence of ornithine decarboxylase-immunoreactive neurons in the rat brain. Neurosci. Lett. 76, 269-274.
32. Cintra A., Fuxe K., Harfstrand A., Agnati L. F., Tinner B., Wikstrom A.-C., et al. (1987b) Evidence for the presence of glucocorticoid receptor immunoreactivity in corticotropin-releasing factor and in growth hormone releasing factor immunoreactive neurones of the rat di- and telencephalon. Neurosci. Lett. 76 275-280.
33. Clark A. S., Mitre M. C. and Brinck-Johnsen T. (1995) Anabolic-androgenic steroid and adrenal steroid effects on hippocampal plasticity. Brain Res. 679, 64-71.
34. Coleman P. D. and Flood D. G. (1987) Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol. Aging 8, 521-545.
35. Coyle J. T., Ferkany J. W. and Zaczek R. (1983) Kainic acid: insights from a neurotoxin into the pathophysiology of Huntington's disease. Neurobehav. Tox. Teratol. 5, 617-624.
36. Cunningham J. J., Calles-Escandon J., Garrido F., Carr D. B. and Bode H. H. (1986) Hypercorticosteronuria and diminished pituitary responsiveness to corticotropin-releasing factor in obese Zucker rats. Endocrinology 118, 98-101.
37. Dachir S., Kadar T., Robinzon B. and Levy A. (1993) Cognitive deficits induced in young rats by long-term corticosterone administration. Behav. Neural Biol. 60, 103-109.
38. Dallman M. F., Akana S. F., Cascio C. S., Darlington D. N., Jacobson L. and Levin N. (1987) Regulation of ACTH secretion: Variations on a theme of B. Recent Prog. Horm. Res. 43, 113-173.
39. Dallman M. F., Strack A. M., Akana S. F., Bradbury M. J., Hanson E. S., Schribner K. A. and Smith M. (1993) Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front. Neuroendocrinol. 14, 303-347.
40. Davis M. (1992) The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci. 15, 353-375.
41. Dawson R., Pelleymounter M. A., Millard W. J., Liu S. and Eppler B. (1997) Attenuation of leptin-mediated effects by monosodium glutamate-induced arcuate nucleus damage. Am. J. Physiol. 273, E202-206.
42. De Bosscher K., Schmitz M. L., Vanden Berghe W., Plaisance S., Fiers W. and Haegeman G. (1997) Glucocorticoid-mediated repression of nuclear factor-κB-dependent transcription involves direct interference with transactivation. Proc. Natl. Acad. Sci. USA 94, 1504-1509.
43. De Goeij D. C. E., Binnekade R. and Tilders F. J. H. (1992a) Chronic stress enhances vasopressin but not corticotropin-releasing factor secretion during hypoglycemia. Am. J. Physiol. 263, E394-E399.
44. De Goeij D. C. E., Dijkstra H. and Tilders F. J. H. (1992b) Chronic psychosocial stress enhances vasopressin but not corticotropin-releasing factor, in the external zone of the median eminence of male rats: relationship to subordinate status. Endocrinology 131, 847-853.
45. De Goeij D. C. E., Jezova D. and Tilders F. J. H. (1992c) Repeated stress enhances vasopressin in corticotropin-releasing factor neurons in the paraventricular nucleus. Brain Res. 577, 165-168.
46. De Leon M. J., McRae T., Tsai J. R., George A. E., Marcus D. L., Freedman M., et al. (1988) Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy. Lancet 2, 391-392.
47. De Vos P., Saladin R., Auwerx J. and Staels B. (1995) Induction of ob gene expression by cordcosteroids is accompanied by body weight loss and reduced food intake. J. Biol. Chem. 270, 15958-15961.
48. Devenport L., Knehans A., Sundstrom A. and Thomas T. (1989) Corticosterone's dual metabolic actions. Life Sci. 45, 1389-1396.
49. Diorio D., Viau V. and Meaney M. J. (1993) The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J. Neurosci. 13, 3839-3847.
50. Dohanics J., Kovacs K. J., Folly G. and Makara G. B. (1990) Long term salt loading impairs pituitary responsiveness to ACTH secretagogues and stress in rats. Peptides 11, 59-63.
51. Dornhorst A., Carlson D. E., Seif S. M., Robinson A. G., Zimmerman E. A. and Gann D. S. (1981) Control of release of adrenocorticotropin and vasopressin by the supraoptic and paraventricular nuclei. Endocrinology 108, 1420-1424.
52. +-dependent L-glutamate transport activity in C6 glioma cells by phorbol ester. J. Neurochem. 67, 508-516.
53. Doyle P., Rohner-Jeanrenaud F. and Jeanrenaud B. (1993) Local cerebral glucose utilization in brains of lean and genetically obese (fa/fa) rats. Am. J. Physiol. 264, E29-36.
54. Dunn J. D. (1987) Plasma corticosterone responses to electrical stimulation of the bed nucleus of the stria terminalis. Brain Res. 407, 327-331.
55. Dunn J. D. and Whitener J. (1986) Plasma corticosterone responses to electrical stimulation of the amygdaloid complex: Cytoarchitectural specificity. Neuroendocrinology 42, 211-217.
56. Eleftheriou B. E., Elias M. F. and Norman R. L. (1972) Effects of amygdaloid lesions on reversal learning in the deermouse. Physiol. Behav. 9, 69-73.
57. Elkabir D. R., Wyatt M. E., Vellucci S. V. and Herbert J. (1990) The effects of separate or combined infusions of corticotrophin-releasing factor and vasopressin either intraventricularly or into the amygdala on aggressive and investigative behaviour in the rat. Regul. Pept. 28, 199-214.
58. Elliott E. and Sapolsky R. (1992) Corticosterone enhances kainic acid-induced calcium mobilization in cultured hippocampal neurons. J. Neurochem. 59, 1033-1039.
59. Elliott E. and Sapolsky R. (1993) Corticosterone impairs hippocampal neuronal calcium regulation: Possible mediating mechanisms. Brain Res. 602, 84-89.
60. Emoto H., Koga C., Ishii H., Yokoo H., Yoshida M. and Tanaka M. (1993) A CRF antagonist attenuates stress-induced increases in NA turnover in extended brain regions in rats. Brain Res. 627, 171-176.
61. Faden A. L., Demediuk P., Panter S. S. and Vink R. (1989) The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244, 798-800.
62. Fagg G. E. and Foster A. C. (1983) Amino acid neurotransmitters and their pathways in the mammalian central nervous system. Neuroscience 9, 701-719.
63. Falls W. A., Miserendino M. J. D. and Davis M. (1992) Extinction of fear-potentiated startle: Blockade by infusion of an NMDA antagonist into the amygdala. J. Neurosci. 12, 854-863.
64. Farb C., Aoki C., Milner T., Kaneko T. and LeDoux J. (1992) Glutamate immunoreactive terminals in the lateral amygdaloid nucleus: A possible substrate for emotional memory. Brain Res. 593, 2517-2529.
65. Feldman S. and Conforti N. (1976) Feedback effects of dexamethasone on adrenocortical responses in rats with fornix lesions. Horm. Res. 7, 56-60.
66. Fine S. M., Angel R. A., Perry S. W., Epstein L. G., Rothstein J. D., Dewhurst S. and et al. (1996) Tumor necrosis factor a inhibits glutamate uptake by primary human astrocytes. J. Biol. Chem. 271, 15303-15306.
67. Fischette C., Kosimurak B., Ediner H., Feder H. H. and Siegal A. (1980) Differential fornix ablations and the circadian rhythmicity of adrenal corticosterone secretion. Brain Res. 195, 373-380.
68. Fukushima M., Nakai Y., Tsukada T., Naito Y., Nakaishi S., Tominaga T., et al. (1992) Immunoreactive corticotropin-releasing hormone levels in the hypothalamus of female Wistar fatty rats. Neurosci. Lett. 138, 245-248.
69. Gabr R. W., Birkle D. L. and Azzaro A. J. (1995) Stimulation of the amygdala by glutamate facilitates corticotropin-releasing factor release from the median eminence and activation of the hypothalamic-pituitary-adrenal axis in stressed rats. Neuroendocrinology 62, 333-339.
70. Gay V. L. and Plant T. M. (1987) N-methyl-D, L-aspartate elicits hypothalamic gonadotropin-releasing hormone release in prepubertal male rhesus monkeys (Macaca mulatta). Endocrinology 120, 2289-2296.
71. Gegelashvili G., Civenni G., Racagni G., Danbolt N. C., Schousboe I. and Schousboe A. (1996) Glutamate receptor agonists up-regulate glutamate transporter GLAST in astrocytes. Neuroreport 8, 261-265.
72. Globus M. Y., Busto R., Dietrich W. D., Martinez E., Valdes I. and Ginsberg M. D. (1988) Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. J. Neurochem. 51, 1455-1464.
73. Glowa J. R., Barrett J. E., Russell J. and Gold P. W. (1992) Effects of corticotropin releasing hormone on appetitive behaviors. Peptides 13, 609-621.
74. Gold P. W., Licinio J., Wong M.-L. and Chrousos G. P. (1995) Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann. NY. Acad. Sci. 771, 716-729.
75. Goujon E., Parnet P., Cremona S. and Dantzer R. (1995) Endogenous glucocorticoids down regulate central effects of interleukin-1 beta on body temperature and behaviour in mice. Brain Res. 702, 173-180.
76. Gray J. A. (1982) The Neuropsychology of Anxiety. Clarendon, Oxford.
77. Gray J. A. and McNaughton N. (1983) Comparison between the behavioural effects of septal and hippocampal lesions: A review. Neurosci. Biobehav. Rev. 7, 119-188.
78. Gray T. S., Carney M. E. and Magnuson D. J. (1989) Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: Possible role in stress-induced adrenocorticotropin release. Neuroendocrinology 50, 433-446.
79. Gray T. S., Piechowski R. A., Yracheta J. M., Rittenhouse P. A., Bethea C. L. and Van de Kar L. D. (1993) Ibotenic acid lesions in the bed nucleus of the stria terminalis attenuate conditioned stress-induced increases in prolactin, ACTH and corticosterone. Neuroendocrinology 57, 517-524.
80. Greenamyre J. T. and Porter R. H. (1994) Anatomy and physiology of glutamate in the CNS. Neurology 44, S7-S13.
81. Greenamyre J. T. and Young A. B. (1989) Excitatory amino acids and Alzheimer's disease. Neurobiol. Aging 10, 593-602.
82. Gurevich D., Siegel B., Dumlao M., Perl E., Chaitin P., Bagne C., et al. (1990) HPA axis responsivity to dexamethasone and cognitive impairment in dementia. Prog. Neuropsychopharmacol. Biol. Psychiatry 14, 297-308.
83. Hanisch U. K., Rowe W., Sharma S., Meany M. J. and Quirion R. (1994) Hypothalamic-pituitary-adrenal activity during chronic central administration of interleukin-2. Endocrinology 135, 2465-2472.
84. Harbuz M. S., Stephanou, A., Sarlis, N. and Lightman, S. L. (1992) The effects of recombinant human interleukin (IL)-1 alpha, IL-1 beta or IL-6 on hypothalamo-pituitary-adrenal axis activation. J. Endocrinol. 133, 349-355.
85. Hardwick A. J., Linton E. A. and Rothwell N. J. (1989) Thermogenic effects of the antiglucocorticoid RU-486 in the rat: involvement of corticotropin-releasing factor and sympathetic activation of brown adipose tissue. Endocrinology 124, 1684-1688.
86. Hashimoto K., Suemaru S., Takao T., Sugawara M., Makino S. and Fensuka O. (1998) Corticotropin-releasing hormone and pituitary-adrenocortical responses in chronically stressed rats. Regul. Pept. 23, 117-126.
87. Hatzinger M., Z'brun A., Hemmeter U., Seifritz E., Baumann F., Holsboer-Trachsler E. et al. (1995) Hypothalamic-pituitary-adrenal system function in patients with Alzheimer's disease. Neurobiol. Aging 16, 205-209.
88. Hauger R. L. and Aguilera G. (1992) Regulation of corticotropin-releasing hormone receptors and hypothalamic pituitary adrenal axis responsiveness during cold stress. J. Neuroendocrinol. 4, 617-624.
89. Hauger R. L., Millan M. A., Lorang M., Harwood J. P. and Aguilera G. (1988) Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress. Endocrinology 123, 396-405.
90. Heinrichs S. C., Lapsansky J., Behan D. P., Chan R. K., Sawchenko P. E., Lorang M., et al. (1996) Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal. Proc. Natl. Acad. Sci. USA 93, 15475-15480.
91. Herman J. O., Cullinan W. E. and Watson S. J. (1994) Involvement of the bed nucleus of the stria terminalis in tonic regulation of paraventricular hypothalamic CRH and AVP mRNA expression. J. Neuroendocrinol. 6, 433-442.
92. Herman J. P., Adams D. and Prewitt C. (1995) Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology 61, 180-190.
93. Holt S. and York D. A. (1982) The effect of adrenalectomy on GDP binding to brown-adipose-tissue mitochondria of obese rat. Biochem. J. 208, 819-822.
94. Honkaniemi J., Pelto-Huikko M., Rechardt L., Isola J., Lammi A., Fuxe K., et al. (1992) Colocalization of peptide and glucocorticoid receptor immunoreactivities in rat central amygdaloid nucleus. Neuroendocrinology 55, 451-459.
95. Horel J. A. (1978) The neuroanatomy of amnesia. A critique of the hippocampal memory hypothesis. Brain 101, 403-445.
96. Horner H., Packan D. and Sapolsky R. (1990) Glucocortioicds inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology 52, 57-62.
97. Hu Y., Dietrich, H., Herold, M., Heinrich, P. C. and Wick, G. (1993) Disturbed immuno-endocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune disease. Int. Arch. Allergy Immunol. 102, 232-241.
98. Issa A. M., Rowe W., Gauthier S. and Meany M. J. (1990) Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats. J. Neurosci. 10, 3247-3254.
99. Jacobs L. and Johnson K. P. (1994) A brief history of the use of interferons as treatment of multiple sclerosis. Arch. Neurol. 51, 1245-1252.
100. Jacobson L. and Sapolsky R. (1991) The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr. Rev. 12, 118-134.
101. Jenike M. A. and Albert M. S. (1984) The dexamethasone suppression test in patients with presenile and senile dementia of the Alzheimer's type. J. Am. Geriatr. Soc. 32, 441-444.
102. Jessop D. S., Chowdrey H. S. and Lightman S. L. (1990) Inhibition of rat corticotropin-releasing factor and adrenocorticotropin secretion by an osmotic stimulus. Brain Res. 523, 1-4.
103. Jezova D., Oliver C. and Jurcovicova J. (1991) Stimulation of adrenocorticotropin but not prolactin and catecholamine release by N-methyl-aspartic acid. Neuroendocrinology 54, 488-492.
104. Joanny P., Steinberg J., Oliver C. and Grino M. (1997) Glutamate and N-methyl-D-aspartate stimulate rat hypothalamic corticotropin-releasing factor secretion in vitro. J. Neuroendocrinol. 9, 93-97.
105. Joels M. and De Kloet E. (1989) Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus. Science 245, 110-112.
106. Joels M. and De Kloet E. R. (1994) Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Prog. Neurobiol. 43, 1-36.
107. Johnson C. L. and Johnson C. G. (1993) Substance P regulation of glutamate and cysteine transport in buman astrocytoma cells. Receptors Channels 1, 53-59.
108. Kanai Y., Smith C. P. and Hediger M. A. (1993) A new family of neurotransmitter transporters: The high-affinity glutamate transporters. FASEB J. 7, 1450-1459.
109. Keller J. N., Pang Z., Geddes J. W., Begley J. G., Germeyer A., Waeg G., et al. (1997) Impairment of glucose and glutamate transport, and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: Role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 269, 273-284.
110. Keller-Wood M. E. and Dallman M. F. (1984) Corticosteroid inhibition of ACTH secretion. Endocr. Rev. 5, 1-24.
111. Kerr D., Campbell E., Thibault O. and Landfield P. (1992) Hippocampal glucocorticoid receptor activation enhances voltage-dependent calcium conductances: Relevance to brain aging. Proc. Natl. Acad. Sci. USA 89, 8527-8531.
112. Killcross S., Robbins T. W. and Everitt B. J. (1997) Different types of fear-conditioned behaviour mediated by separate nuclei within the amygdala. Nature 388, 377-380.
113. King B. M., Arcenaux E. R., Cook J. T., Benjamin A. L. and Alheid G. F. (1996a) Temporal lobe lesion-induced obesity in rats: an anatomical investigation of the posterior amygdala and hippocampal formation. Physiol. Behav. 59, 843-848.
114. King B. M., Cook J. T. and Dallman M. F. (1996b) Hyperinsulinemia in rats with obesity-inducing amygdaloid lesions. Am. J. Physiol. 271, R1156-1159.
115. King B. M., Rossiter K. N., Cook J. T. and Sam H. M. (1997) Amygdaloid lesion-induced obesity in rats in absence of finickiness. Physiol. Behav. 62, 935-938.
116. Kiss A. and Aguilera G. (1993) Regulation of the hypothalamic pituitary adrenal axis during chronic stress: Responses to repeated intraperitoneal hypertonic saline injection. Brain Res. 630, 262-270.
117. Koch M. and Ebert U. (1993) Enhancement of the acoustic startle response by stimulation of an excitatory pathway from the central amygdala/ basal nucleus of Meynert to the pontine reticular formation. Exp. Brain Res. 93, 231-241.
118. Kononen J., Soinila S., Persson H., Honkaniemi J., Hokfelt T. and Pelto-Huikko M. (1994) Neurotrophins and their receptors in the rat pituitary gland: regulation of BDNF and trkB mRNA levels by adrenal hormones. Mol. Brain Res. 27, 347-354.
119. Koob G. F., Heinrichs S. C., Pich E. M., Menzaghi F., Baldwin H., Miczek K., et al. (1993) The role of corticotropin-releasing factor in behavioural responses to stress. Ciba Found. Symp. 172, 277-289.
120. Kremer B., Tallaksen-Greene S. J. and Albin R. L. (1993) AMPA and NMDA binding sites in the hypothalamic lateral tuberal nucleus: implications for Huntington's disease. Neurology 43, 1593-1595.
121. Landfield P. W., Baskin R. K. and Pitler T. A. (1981) Brain aging correlates: Retardation by hormonal-pharmacological treatments. Science 214, 581-584.
122. Langley S. C. and York D. A. (1990) Increased type II glucocorticoid-receptor numbers and glucocorticoid-sensitive enzyme activities in the brain of obese Zucker rat. Brain Res. 533, 268-274.
123. Langley S. C. and York D. A. (1992) Glucocorticoid receptor numbers in the brain and liver of the obese Zucker rat. Int. J. Obes. Relat. Metab. Disord. 16, 135-143.
124. Liang K. C. and Lee E. H. Y. (1988) Intra-amygdala injections of corticotropin releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats. Psychopharmacology 96, 232-236.
125. Lightman S. L. (1994) How does the hypothalamus respond to stress? Neurosciences 6, 215-219.
126. Lindholm D., da Penha Berzaghi M., Cooper J., Thoenen H. and Castren E. (1994) Brain-derived neurotrophic factor and neurotrophin-4 increase neurotrophin-3 expression in the rat hippocampus. Int. J. Dev. Neurosci. 12, 745-751.
127. Lipton S. A. and Rosenberg P. A. (1994) Mechanisms of disease: Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613-622.
128. Liu D., Diorio J., Tannenbaum B., Caldji C., Francis D., Freedman A., et al. (1997) Maternal care, hippocampal glucocorticoid receptors and hypothalamic-pituitary-adrenal responses to stress. Science 277, 1659-1662.
129. Lowy M. T., Gault L. and Yamamoto B. K. (1993) Adrenalectomy attenuates stress-induced elevatrions in extracellular glutamate concentrations in the hippocampus.
130. Lowy M., Wittenberg L. and Novotney S. (1994) Adrenalectomy attenuates kainic acid-induced spectrin proteolysis and heat shock protein 70 induction in hippocampus and cortex. J. Neurochem. 63, 886-893.
131. Lowy M., Wittenberg L. and Yamamoto B. (1995) Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats. J. Neurochem. 65, 268-274.
132. Magariños A. M. and McEwen B. S. (1995) Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Comparison of stressors. Neuroscience 69, 83-88.
133. Magarinos A. M., Verdugo J. M. G. and McEwen B. S. (1997) Chronic stress alters synaptic terminal structure in hippocampus. Proc. Natl. Acad. Sci. USA 94, 14,002-14,008.
134. Makino S., Smith M. A. and Gold P. W. (1995) Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: Association with reduction in glucocorticoid receptor mRNA levels. Endocrinology 136, 3299-3309.
135. Marchington D., Rothwell N. J., Stock M. J. and York D. A. (1983) Energy balance, diet-induced thermogenesis and brown adipose tissue in lean and obese (fa/fa) Zucker rats after adrenalectomy. J. Nutri. 113, 1395-1402.
136. Masliah E., Alford M., DeTeresa R., Mallory M. and Hansen L. (1996) Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann. Neurol. 40, 759-766.
137. Massieu L. and Tapia R. (1997) Glutamate uptake impairment and neuronal damage in young and aged rats in vivo. J. Neurochem. 69, 1151-1160.
138. Mastorakos G., Chrousos, G. P. and Weber, J. S. (1993) Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J. Clin. Endocrinol. Metab. 77, 1690-1694.
139. Mastorakos G., Weber, J. S., Magiakou, M. A., Gunn, H. and Chrousos, G. P. (1994) Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J. Clin. Endocrinol. Metab. 79, 934-939.
140. Matheson G. K., Branch B. J. and Taylor A. N. (1971) Effects of amygdaloid stimulation on pituitary-adrenal activity in conscious cats. Brain Res. 32, 151-167.
141. Mattson M. P. and Rychlik B. (1990) Glia protect hippocampal neurons against excitatory amino acid-induced degeneration: involvement of fibroblast growth factor. Int. J. Dev. Neurosci. 8, 399-415.
142. Mauri M., Sinforiani E., Bono G., Vignati F., Berselli M. E., Attanasio R., et al. Nappi G. (1993) Memory impairment in Cushing's disease. Acta Neurol. Scand. 87, 52-55.
143. McCarthy H. D., McKibbin P. E., Perkins A. V., Linton E. A. and Williams G. (1993) Alterations in hypothalamic NPY and CRF in anorexic tumor-bearing rats. Am. J. Physiol. 264, E638-643.
144. McDonald A. J. (1987) Somatostatinergic projections from the amygdala to the bed nucleus of the stria terminalis and medial preoptic-hypothalamic region. Neurosci. Lett. 75, 271-277.
145. McEwen B. S. (1997) Possible mechanisms for atrophy of the human hippocampus. Mol. Psychiatry 2, 255-262.
146. McEwen B. S., Angulo J., Cameron H., Chao H. M., Daniels D., Gannon M. N., et al. (1992) Paradoxical effects of adrenal steroids on the brain: protection versus degeneration. Biol. Psychiatr. 31, 177-199.
147. McEwen B. S., Conrad C. D., Kuroda Y., Frankfurt M., Magarinos A. M. and McKittrick C. (1997) Prevention of stress-induced morphological and cognitive consequences. Eur. Neuropharmacol. Suppl. 3, S323-328.
148. McEwen B. S., Weiss J. M. and Schwartz L. S. (1968) Selective retention of corticosterone by limbic structures in rat brain. Nature 220, 911-912.
149. McGinnis R., Walker J. and Margules D. (1987) Genetically obese (ob/ob) mice are hypersensitive to glucocortioid stimulation of feeding but dramatically resist glucocorticoid-induced weight loss. Life Sci. 40, 1561-1570.
150. McLay R. N., Freeman S. M., Harlan R. E., Ide C. F., Kastin A. J. and Zadina J. E. (1997) Aging in the hippocampus: Interrelated actions of neurotrophins and glucocorticoids. Neurosci. Behav. Rev. 21, 615-629.
151. Meany M. J., Aitken D. H., van Berkel C., Bhatnagar S. and Sapolsky R. M. (1988) Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 239, 766-768.
152. Meeker R. B., Greenwood R. S. and Hayward J. N. (1993) Glutamate is the major excitatory transmitter in the supraoptic nuclei. Ann. NY Acad. Sci. 689, 636-639.
153. Moghaddam B. (1993) Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: Comparison to hippocampus and basal ganglia. J. Neurochem. 60, 1650-1656.
154. Moghaddam B., Bolinao M., Stein-Behrens B. and Sapolsky R. (1994) Glucocorticoids mediate the stress-induced accumulation of extracellular glutamate. Brain Res. 655, 251-256.
155. Moller C., Wiklund L., Sommer W., Thorsell A. and Heilig M. (1997) Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions. Brain Res. 760, 94-101.
156. Mook D. G., Fischer J. C. and Durr J. C. (1975) Some endocrine influences on hypothalamic hyperphagia. Horm. Behav. 6, 65-79.
157. Morley J. E. (1987) Neuropeptide regulation of appetite and weight. Endocr. Rev. 8, 256-287.
158. Nakaishi S., Nakai Y., Fukata J., Naito Y., Usui T. and Imura T. (1990) Immunoreactive corticotropin-releasing hormone levels in brain regions of genetically obese Zucker rats. Int. J. Obes. 14, 951-955.
159. Nasman B., Olsson T., Fagerlund M., Eriksson S., Viitanen M. and Carlstrom K. (1996) Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease. Biol. Psychol. 39, 311-318.
160. Newcomer J. W., Craft S., Hershey T., Askins K. and Bardgett M. E. (1994) Glucocorticoid-induced impairment in declarative memory in adult humans. J. Neurosci. 14, 2047-2053.
161. Newcomer J. W., Faustman W. O., Whiteford H. A., Moses J. A. and Csernansky J. G. (1991) Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patients. Biol. Psychiatry 29, 855-864.
162. Nicholls D. and Attwell D. (1990) The release and uptake of excitatory amino acids. Trends Pharmacol. Sci. 11, 462-468.
163. Norbiato G., Bevilacqua M., Vago T., Taddei A. and Clerici M. (1997) Glucocorticoids and the immune function in hypercortisolemic and cortisol-resistant patients. J. Clin. Endocrinol. Metab. 82, 3260-3263.
164. O'Brien J. T., Ames D., Schweitzer I., Colman P., Desmond P. and Tress B. (1996) Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease. Br. J. Psychol. 168, 679-687.
165. Oberfield S. E., Cowan L., Levine L. S., George A., David R., Litt A., et al. (1994) Altered cortisol response and hippocampal atrophy in pediatric HIV disease. J. Acquir. Immune Defic. Syndr. 7, 57-62.
166. Oitzl M. S. and De Kloet E. R. (1992) Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav. Neurosci. 106, 62-71.
167. Oitzl M. S., Fluttert M. and De Kloet E. R. (1994) The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticosteroid receptors. Eur. J. Neurosci. 6, 1072-1079.
168. Olney J. W. (1990) Excitotoxicity: an overview. Can. Dis. Weekly Rep. 16 Suppl. 1E, 47-57.
169. Olney J. W., Wozniak D. F., Nuri B. and Farber M. D. (1997) Excitotoxic neurodegeneration in Alzheimer's disease. Arch. Neurol. 54, 1234-1240.
170. Otten U., Baumann J. B. and Girard J. (1979) Stimulation of the pituitary-adrenocortical axis by nerve growth factor. Nature 282, 1713-1721.
171. Pacak K., McCarty R., Palkovits M., Cizza G., Kopin I., Glodstein D. S., et al. (1995) Decreased central and peripheral catecholaminergic activation in obese Zucker rats. Endocrinology 136, 4360-4367.
172. Pasquali R., Anconetani B., Chattat R., Biscotti M., Spinucci G., Casimirri F., et al. (1996) Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: Effects of the corticotropin-releasing factor/arginine vasopressin test and of stress. Metabolism 45, 351-356.
173. Pasquali R., Cantobelli S., Casamirri S., et al. (1993) The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J. Clin. Endocrinol. Metab. 77, 341-346.
174. Patchev V. K., Karalis K. and Chrousos G. P. (1994) Effects of excitatory
175. Pich E. M., Lorang M., Yeganeh M., Rodriguez de Fonseca F., Raber J., Koob G. F., et al. (1995) Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 15, 5439-5447.
176. Pitkanen A., Savander V. and LeDoux J. E. (1997) Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala. Trends Neurosci. 20, 517-523.
177. Plotsky P. M. and Sawchenko P. E. (1987) Hypophyseal portal plasma levels, median eminence content and immunohistochemical staining of corticotropin releasing factor, arginine vasopressin and oxytocin after pharmacological adrenalectomy. Endocrinology 120, 1361-1369.
178. Plotsky P. M., Thrivikraman K. V., Watts A. G. and Hauger R. L. (1992) Hypothalamic-pituitary-adrenal axis function in the Zucker obese rat. Endocrinology 130, 1931-1941.
179. Porter R. H. P. and Greenamyre J. T. (1995) Regional variations in the pharmacology of NMDA receptor channel blockers: Implications for therapeutic potential. J. Neurochem. 64, 614-623.
180. Poucet B. and Benhanou S. (1997) The neuropsychology of spatial cognition in the rat. Crit. Rev. Neurobiol. 11, 101-120.
181. Quirarte G. L., Roozendaal B. and McGaugh J. L. (1997) Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala. Proc. Natl. Acad. Sci. USA 94, 14048-14053.
182. Raber J., Chen S., Mucke L. and Feng L. (1997a) Corticotropin-releasing factor and adrenocorticotrophic hormone as potential central mediators of OB effects. J. Biol. Chem. 272, 15057-15060.
183. Raber J., O'Shea R. D., Bloom F. E. and Campbell I. L. (1997b) Modulation of hypothalamic-pituitary-adrenal function by transgenic expression of interleukin-6 in the CNS of mice. J. Neurosci. 17, 9743-9480.
184. Raber J., Toggas S. M., Lee S., Bloom F. E., Epstein C. J. and Mucke L. (1996) Central nervous system expression of HIV-1 gp120 activates the hypothalamic-pituitary-adrenal axis: Evidence for involvement of NMDA receptors and nitric oxide synthase. Virology 226, 362-373.
185. Rapp P. R. and Gallagher M. (1996) Preserved neuron number in the hippocampus of aged rats with spatial learning deficits. Proc. Natl. Acad. Sci. USA 93, 9926-9930.
186. Redgate E. S. and Fahringer E. E. (1973) A comparison of the pituitary adrenal activity elicited by electrical stimulation of preoptic, amygdaloid and hypothalamic sites in the rat brain. Neuroendocrinology 12, 334-343.
187. Reid I. R., Wattie D. J., Evans M. C. and Stapleton J. P. (1996) Testosterone therapy in glucocorticoid-treated men. Arch. Med. 156, 1173-1177.
188. Reul J. M. H. M. and De Kloet E. R. (1986) Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitro autoradiography and computerized image analysis. J. Steroid Biochem. 24, 269-272.
189. Reus V. I. (1984) Hormonal mediation of the memory disorder in depression. Drug Dev. Res. 4, 489-500.
190. Reyes A., Luckhaus J. and Ferin M. (1990) Unexpected inhibitory action of N-methyl-D-aspartate on luteinizing hormone release in adult ovariectomized rhesus monkeys: A role for the hypothalamic-pituitary-adrenal axis. Endocrinology 127, 724-729.
191. Ribeiro E. B., do Nascimento C. M., Andrade I. S., Hirata A. E. and Dolnikoff M. S. (1997) Hormonal and metabolic adaptations to fasting in monosodium glutamate-obese rats. J. Comp. Biol. 167, 430-437.
192. Richard D., Rivest R., Naimi N., Timofeeva E. and Rivest S. (1996) Expression of corticotropin-releasing factor and its receptors in the brain of lean and obese Zucker rats. Endocrinology 137, 4786-4795.
193. Rivest S. and Richard D. (1990) Involvement of corticotropin-releasing factor in the anorexia induced by exercise. Brain Res. Bull. 25, 169-172.
194. Robinson M. B. and Coyle J. T. (1987) Glutamate and related acidic excitatory neurotransmitters: From basic science to clinical application. FASEB J. 1, 446-455.
195. Rohner-Jeanrenaud F., Walker C. D., Greco-Perotto R. and Jeanrenaud B. (1989) Central corticotropin-releasing factor administration prevents excessive body weight gain of genetically obese (fa/fa) rats. Endocrinology 124, 733-739.
196. Rothstein J. D. (1996) Excitotoxicity hypothesis. Neurology 47, S19-S25.
197. Rothstein J. D. and Kuncl R. W. (1995) Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J. Neurochem. 65, 643-651.
198. Rothstein J. D., Dykes-Hoberg M., Pardo C. A., Bristol L. A., Jin L., Kuncl R. W., et al. (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675-686.
199. Rothwell N. J. (1990) Central activation of thermogenesis by prostaglandins: dependence on CRF. Harm. Metab. Res. 22, 616-618.
200. Saito M. and Bray G. A. (1984) Adrenalectomy and food restriction in the genetically obese (ob/ob) mouse. Am. J. Physiol. 246, R20-25.
201. Sakanaka M., Shibasaki T. and Lederis K. (1986) Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res. 382, 213-238.
202. Sandberg M., Butcher S. P. and Hagberg H. (1986) Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in vivo dialysis of the rat hippocampus. J. Neurochem. 47, 178-184.
203. Saphier D. (1987) Cortisol alters firing rate and synaptic responses of limbic forebrain units. Brain Res. Bull. 19, 519-524.
204. Sapolsky R. M. (1992) Stress, the Aging Brain, and the Mechanisms of Neuron Death. MIT Press, Cambridge, MA.
205. Sapolsky R. M. (1994) Individual differences and the stress response. Semin. Neurosci. 6, 261-269.
206. Sapolsky R. M. (1996) Stress, glucocorticoids, and damage to the nervous system: The current state of confusion. Stress 1, 1-19.
207. Sapolsky R. M., Krey L. C. and McEwen B. S. (1985) Prolonged glucocorticoid exposure reduces hippocampal neuron number: Implications for aging. J. Neurosci. 5, 1222-1227.
208. Sapse A. T. (1997) Cortisol, high cortisol diseases and anti-cortisol therapy. Psychoneuroendocrinology 22 Suppl. 1, S3-10.
209. Scaccianoce S., Musculo L. A. A., Cigliana G., Navarra D., Nicolai R. and Angelucci L. (1991) Evidence for a specific role of vasopressin in sustaining pituitary-adrenocortical stress response in rat. Endocrinology 128, 3138-3143.
210. Scheinman R. I., Cogswell P. C., Lofquist A. K. and Baldwin A. S. (1995) Role of transcriptional activation of Iκ Bα in mediation of immunosuppression by glucocorticoids. Science 270, 283-286.
211. Schmidt E. D., Binnekade R., Janszen A. W. and Tilders F. J. (1996) Short stressor induced long-lasting increases of vasopressin stores in hypothalamic corticotropin-releasing hormone (CRH)-neurons in adult rats. J. Neuroendocrinol. 8, 703-712.
212. Schmidt E. D., Janszen A. W., Wouterlood F. G. and Tilders F. J. (1995) Interleukin-1-induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)-neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis. J. Neurosci. 15, 7417-7426.
213. Scott H. L., Tannenberg A. E. G. and Dodd P. R. (1995) Variant forms of neuronal glutamate transporter sites in Alzheimer's disease cerebral cortex. J. Neurochem. 64, 2193-2202.
214. Scully J. L. and Otten U. (1995a) Neurotrophin expression modulated by glucocorticoids and oestrogen in immortalized hippocampal neurons. Mol. Brain Res. 31, 158-164.
215. Scully J. L. and Otten U. (1995b) Glucocorticoids, neurotrophins and neurodegeneration. J. Steroid Biochem. Mol. Biol. 52, 391-401.
216. Segal R. A., Pomeroy, S. L. and Stiles, C. D. (1995) Axonal growth and fasicculation linked to differential expression of BDNF and NT3 receptors in developing cerebellar granule cells. J. Neurosci. 15, 4970-4981.
217. Shibasaki T., Yamauchi N., Kato Y., Masuda A., Imaki T., Hotta M., et al. (1988) Involvement of corticotropin-releasing factor in restraint stress-induced anorexia and reversion of the anorexia by somatostatin in the rat. Life Sci. 43, 1103-1110.
218. 3H]glutamate uptake into synaptosomes. J. Neurochem. 47, 1614-1619.
219. Singh V. B., Onaivi E. S., Phan T.-H. and Boadle-Biber M. C. (1990) The increases in rat cortical and midbrain tryptophan hydroxylase activity in response to acute or repeated sound stress are blocked by bilateral lesions to the central nucleus of the amygdala. Brain Res. 530, 49-53.
220. Slieker L. J., Sloop K. W., Surface P. L., Kriauciunas A., LaQuier F., Manetta J., et al. (1996) Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J. Biol. Chem. 271, 5301-5304.
221. Smith M. A. (1996) Hippocampal vulnerability to stress and aging: Possible role of neurotrophic factors. Behav. Brain Res. 78, 25-36.
222. Smith M. A., Makino S., Altemus M., Michelson D., Hong S. K., Kvetnansky R., et al. (1995) Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus. Proc. Natl. Acad. Sci. USA 92, 8788-8792.
223. Smythe J. W., Murphy D., Timothy C. and Costall B. (1997) Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behaviour in rats. Pharmacol. Biochem. Behav. 56, 507-513.
224. Spath-Schwalbe E., Born, J., Schrezenmeier, H., Bornstein, S. R., Stromeyer, P., Drechsler, S., et al. (1994) Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man. J. Clin. Endocrinol. Metab. 79, 1212-1214.
225. Spina M., Merlo-Pich E., Chan R. K., Basso A. M., Rivier J., Vale W., et al. (1996) Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273, 1561-1564.
226. Starkman M. N., Schteingart D. E. and Schork M. A. (1986) Cushing's syndrome after treatment: changes in cortisol and ACTH levels, and amelioration of the depressive syndrome. Psychiatry Res. 19, 177-188.
227. Stein-Behrens B. A., Elliot E. M., Miller C. A., Schilling J. W., Newcombe R. and Sapolsky R. M. (1992) Glucocorticoids exacerbate kainic acid-induced extracellular accumulation of excitatory amino acids in the rat hippocampus. J. Neurochem. 58, 1730-1736.
228. Stein-Behrens B. A., Lin W. J. and Sapolsky R. M. (1994) Physiological elevations of glucocorticiods potentiate glutamate accumumalation in the hippocampus. J. Neurochem. 63, 596-602.
229. Sutton R. E., Koob G. F., Moal M. L., Rivier J. and Vale W. (1982) Corticotropin releasing factor produces behavioural activation in rats. Nature 297, 331-333.
230. Takahashi L. K., Kalin N. H., Burgt J. A. V. and Sherman J. E. (1989) Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats. Behav. Neurosci. 103, 648-654.
231. Tannahill L. A., Sheward W. J., Robinson I. C. and Fink G. (1991) Corticotrophin-releasing factor-41, vasopressin and oxytocin release into hypophysial portal blood in the rat: effects of electrical stimulation of the hypothalamus, amygdala and hippocampus. J. Endocrinol. 129, 99-107.
232. Vago T., Clerici M. and Norbiato G. (1994) Glucocorticoids and the immune system in AIDS. Bailliere's Clin. Endocrinol. Metab. 8, 789-802.
233. Vaughan J., Donaldson C., Bittencourt J., Perrin M. H., Lewis K., Button S., et al. (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378, 287-292.
234. Vesce S., Bezzi P., Rossi D., Meldolesi J. and Volterra A. (1997) HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid. FEBS Lett. 411, 107-109.
235. Virgin C., Ha T., Packan D., Tombaugh G., Yang S., Horner H., et al. (1991) Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: Implications for glucocorticoid neurotoxicity. J. Neurochem. 57, 1422-1428.
236. Watanabe Y., Gould E., Cameron H. A., Daniels D. C. and McEwen B. S. (1992) Phenytoin prevents stress- and corticosterone-induced atrophy of CA3 pyramidal neurons. Hippocampus 2, 431-435.
237. Weiner M. F., Vobach S., Olsson K., Svetlik D. and Risser R. C. (1997) Cortisol secretion and Alzheimer's disease progression. Biol. Psychol. 42, 1030-1038.
238. Whelan T. B., Schteingart D. E., Starkman M. N. and Smith A. (1980) Neuropsychological deficits in Cushing's syndrome. J. Nerv. Ment. Dis. 168, 753-757.
239. Whitnall M. H. (1993) Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog. Neurobiol. 40, 573-629.
240. Wilckens T. (1995) Glucocorticoids and immune function: physiological relevance and pathogenic potential of hormonal dysfunction. Trends Pharmacol. Sci. 16, 193-197.
241. Wilson L. D., Truong M. P., Narber A. R. and Aoki T. T. (1996) Anterior pituitary and pituitary-dependent target organ function in men infected with the human imunodeficiency virus. Metabol. Clin. Exp. 45, 738-746.
242. Wolkowitz O. M., Reus V. I., Weingartner H., Thompson K., Breier A., Doran A., et al. (1990) Cognitive effects of corticosteroids in man. Am. J. Psychiatry 147, 1297-1303.
243. Woolley C. S., Gould E. and McEwen B. S. (1990) Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 531, 225-231.
244. Ye Z. C. and Sontheimer H. (1996) Cytokine modulation of glial glutamate uptake: a possible involvement of nitric oxide. Neuroreport 7, 2181-2185.
245. Yukimara Y., Bray G. A. and Wolfsen A. R. (1978) Some effects of adrenalectomy in the fatty rat. Endocrinology 103, 1924-1928.
246. Zerangue N., Arriza J. L. and Kavanaugh M. P. (1995) Differential modulation of human glutamate transporter subtypes by arachidonic acid. J. Biol. Chem. 270, 6433-6435.